(Q35210732)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S. Vincent Rajkumar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

9

Litzow MR

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

13

Gertz MA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

7

Lacy MQ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Ghobrial IM

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Bundy KL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Gastineau DA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Therneau TM

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Witzig TE

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Christensen BR

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Hayman S

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Pribula CG

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

587-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12953131%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704173

7 November 2019

exact match

0 references

cites work

Angiogenesis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Thalidomide: a novel template for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Thalidomide for previously untreated indolent or smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Therapeutic dilemmas with thalidomide in multiple myeloma: case discussions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Therapeutic application of thalidomide in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Novel therapies targeting the myeloma cell and its bone marrow microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Thalidomide and the immune system. 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

Peripheral blood stem cell transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

7 January 2021

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

7 January 2021

Factors influencing platelet recovery after blood cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

7 January 2021

Thalidomide in the treatment of relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

7 January 2021

Difference between expression of adhesion molecules on CD34+ cells from bone marrow and G-CSF-stimulated peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

7 January 2021

Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

7 January 2021

Mobilization of CD34+ haematopoietic stem cells is associated with a functional inactivation of the integrin very late antigen 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704173

7 January 2021